{"disease":{"id":"neoplasms-pancreatic","name":"neoplasms pancreatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT07072143","title":"An International Study on Pediatric Patients With Rare Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT04949282","title":"Spanish Series of Patients Treated With the Radionuclide Lutetium177","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Sociedad Española de Medicina Nuclear e Imagen Molecular","has_results":false},{"nct_id":"NCT04291651","title":"UCSF PANC Cyst Registry","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04161417","title":"Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Judith Dixon-Hughes","has_results":false},{"nct_id":"NCT06388967","title":"Pancreatic Cancer Detection Consortium","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03400280","title":"POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT04053998","title":"Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org","phase":"","overall_status":"COMPLETED","enrollment_count":1462,"lead_sponsor_name":"Royal Free Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT07035587","title":"Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04389632","title":"A Study of Sigvotatug Vedotin in Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":1006,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT06131840","title":"A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":914,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT01964430","title":"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the \"Apact\" Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":866,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT05208762","title":"A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":714,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT07535125","title":"IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"A.O.U. Città della Salute e della Scienza","has_results":false},{"nct_id":"NCT02568267","title":"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":534,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT01631552","title":"Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04151277","title":"PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Judith Dixon-Hughes","has_results":false},{"nct_id":"NCT04493632","title":"OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"OncoSil Medical Limited","has_results":false},{"nct_id":"NCT07034495","title":"Laparotomy, Laparoscopy, da Vinci System","phase":"","overall_status":"COMPLETED","enrollment_count":486,"lead_sponsor_name":"National Chung Hsing University","has_results":false},{"nct_id":"NCT02494037","title":"The Canadian/US Integrative Oncology Study","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"The Canadian College of Naturopathic Medicine","has_results":false},{"nct_id":"NCT06947395","title":"Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)","phase":"","overall_status":"COMPLETED","enrollment_count":386,"lead_sponsor_name":"Immunovia, Inc.","has_results":false},{"nct_id":"NCT06118125","title":"Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement","phase":"","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"University of Bordeaux","has_results":false},{"nct_id":"NCT03485209","title":"Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":352,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT05429203","title":"Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope","phase":"NA","overall_status":"COMPLETED","enrollment_count":319,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT05547074","title":"A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT06939023","title":"Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)","phase":"NA","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT02632448","title":"A Study of LY2880070 in Participants With Advanced or Metastatic Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Esperas Pharma Inc.","has_results":false},{"nct_id":"NCT03631173","title":"Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":201,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT06819215","title":"Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":188,"lead_sponsor_name":"Zhejiang Yangli Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT03817866","title":"Chromogranin A as Blood Marker in Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Brahms AG","has_results":false},{"nct_id":"NCT01478685","title":"A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT02376699","title":"Safety Study of SEA-CD40 in Cancer Patients","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":159,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT02784353","title":"Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04566614","title":"Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT03063554","title":"EUS BD vs ERCP TP for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT02309177","title":"Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT04665921","title":"A Study of SGN-STNV in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":111,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT04137289","title":"A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT06885697","title":"Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02310230","title":"An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Donald Mathews","has_results":true},{"nct_id":"NCT07139236","title":"Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT07160283","title":"The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"The Second Affiliated Hospital of Shandong First Medical University","has_results":false},{"nct_id":"NCT06980792","title":"Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria di Modena","has_results":false},{"nct_id":"NCT04042480","title":"A Study of SGN-CD228A in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":88,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT05587088","title":"Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":82,"lead_sponsor_name":"Hospital Universitario San Ignacio","has_results":false},{"nct_id":"NCT02077933","title":"Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03948763","title":"A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":70,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05983133","title":"A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT04752215","title":"A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}